COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,140 Articles (22,693 medRxiv, 8,447 bioRxiv)

Most recent first Previous |  Page 1657: Articles 16561-16570  | Next

Increased angiotensin-converting enzyme 2, sRAGE and immune activation, but lowered calcium and magnesium in COVID-19: association with chest CT abnormalities and lowered peripheral oxygen saturation.
Al-Hakeim, H., Al-Jassas, H., Morris, G., Maes, M.
10.1101/2021.03.26.21254383 — Posted: 2021-03-26
COVID-19 RT-PCR diagnostic assay sensitivity and SARS-CoV-2 transmission: A missing link?
Sahajpal, N. S., Chin Lip Hon, E., Dallaire, S., Williams, C., Ananth, S., Mondal, A. K., Rojiani, A. M., Hegde, M., Kolhe, R.
10.1101/2021.03.24.21254271 — Posted: 2021-03-26
The interplay of policy, behavior, and socioeconomic conditions in early COVID-19 epidemiology in Georgia
Harris, M. J., Tessier-Lavigne, E., Mordecai, E. A.
10.1101/2021.03.24.21254256 — Posted: 2021-03-26
Emergence of N antigen SARS-CoV-2 genetic variants escaping detection of antigenic tests
Del Vecchio, C., Brancaccio, G., Brazzale, A. R., Lavezzo, E., Onelia, F., Franchin, E., Manuto, L., Bianca, F., Cianci, V., Cattelan, A., Toppo, S., Crisanti, A.
10.1101/2021.03.25.21253802 — Posted: 2021-03-26
Why COVID-19 is not so spread in Africa: How does Ivermectin affect it?
Tanioka, H., Tanioka, S., Kaga, K.
10.1101/2021.03.26.21254377 — Posted: 2021-03-26 Discussion: Onsite
From loss to recovery: how to effectively assess chemosensory impairments during COVID-19 pandemic
Cecchetto, C., Di Pizio, A., Genovese, F., Calcinoni, O., Macchi, A., Dunkel, A., Ohla, K., Spinelli, S., Farruggia, M. C., Joseph, P. V., Menini, A., Cantone, E., Dinnella, C., Cecchini, M. P., D'Errico, A., Mucignat-Caretta, C., Parma, V., Dibattista, M.
10.1101/2021.03.25.21254253 — Posted: 2021-03-26
From classic to rap: Airborne transmission of different singing styles, with respect to risk assessment of a SARS-CoV-2 infection
Richter, B., Hipp, A. M., Schubert, B., Axt, M. R., Stratmann, M., Schmoelder, C., Spahn, C.
10.1101/2021.03.25.21253694 — Posted: 2021-03-26
Hemodialysis Patients Show a Highly Diminished Antibody Response after COVID-19 mRNA Vaccination Compared to Healthy Controls
Simon, B., Rubey, H., Treipl, A., Gromann, M., Hemedi, B., Zehetmayer, S., Kirsch, B.
10.1101/2021.03.26.21254259 — Posted: 2021-03-26
Re-opening schools in a context of low COVID-19 contagion: Consequences for teachers, students and their parents
Godoy, A. A., Hart, R. K., Groetting, M. W.
10.1101/2021.03.25.21254219 — Posted: 2021-03-26
Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study
Li, X., Ostropolets, A., Makadia, R., Shoaibi, A., Rao, G., Sena, A. G., Martinez-Hernandez, E., Delmestri, A., Verhamme, K., Rijnbeek, P., Duarte-Salles, T., Suchard, M. A., Ryan, P. B., Hripcsak, G., PRIETO-ALHAMBRA, D.
10.1101/2021.03.25.21254315 — Posted: 2021-03-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).